Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
943319-70-8
Purity
95%
Ponatinib is a kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML).
Properties
Name
Ponatinib
Smiles
CN1CCN(CC=2C=CC(NC(=O)C=3C=CC(C)=C(C#CC4=CN=C5C=CC=NN45)C3)=CC2C(F)(F)F)CC1
Targets
Please log in to see this information
SDS
AP24534 | Iclusig | ponatinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$37
2 mg
$39
5 mg
$41
10 mg
$43
15 mg
$45
20 mg
$48
25 mg
$53
30 mg
$55
35 mg
$58
40 mg
$60
45 mg
$63
50 mg
$65
75 mg
$68
100 mg
$POA
Quantity
1
Total amount
$ 41
AP24534 | Iclusig | ponatinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.